This Week in Cannabis: Will the Next U.S. Attorney General be Good on Cannabis Policy?

A number of newsworthy items occurred this week, including a potential hands-off enforcement policy at the federal level.

Cannabis exports are coming to an international cannabis-leading nation, fewer people are going to be arrested for cannabis in a major metro area, and some good news is on its way in New Jersey.

Find out more in our weekly recap below.

Attorney General nominee puts his hands-off cannabis enforcement pledge in writing

What happened: United States Attorney General nominee William Barr has previously expressed verbal support for allowing legal cannabis states to proceed without federal interference.

This week William Barr put that pledge in writing via his written responses to Senator’s questions as part of his confirmation proceedings.

Why it matters: It wasn’t that long ago that Jeff Sessions was the United States Attorney General, and the cannabis industry and reform movement was bracing itself for a federal crackdown.

Zoom forward to this week and his permanent replacement is providing a written pledge to respect states’ cannabis policies. That’s a very big (and welcomed) change!

Israel approves cannabis exports

What happened: Israel has long been a global leader in cannabis research, and soon it will be a world leader on cannabis exports.

This week leaders in Israel approved medical cannabis exports, which is a long overdue policy change for the Middle Eastern nation.

Why it matters: Israel is home to some of the top medical cannabis researchers on earth, including Raphael Mechoulam who first identified THC.

Patients around the world should be able to benefit from Israel’s knowledge, and fortunately, that will happen soon.

Baltimore to stop pursuing cannabis possession cases

What happened: The Baltimore State Attorney announced this week that it would no longer be pursuing cannabis possession cases.

A push is also underway to vacate convictions for cannabis possession cases (as many as 5,000).

Why it matters: The enforcement change is not the same as saying that cannabis has been legalized but it is still a huge move.

People who are caught with cannabis often have their lives ruined, both at the time of the prosecution and after, via stigma and a criminal record. That should never happen to anyone.

Survey: most healthcare providers believe that medical cannabis is a legitimate medical therapy

What happened: Researchers conducted a survey of healthcare providers and asked them about their views on medical cannabis.

The survey found that 58.1% of providers “strongly agreed” or “somewhat agreed” that medical cannabis was a legitimate medical therapy.

Why it matters: Medical decisions should be made by medical professionals, and not by politicians who seek to keep cannabis prohibition in place.

The results of this survey strongly suggest that if medical professionals had it their way, medical cannabis would be made available to those who would benefit from it.

New Jersey approves medical cannabis for opioid use disorder

What happened: New Jersey passed a measure this week that allows patients who suffer from opioid use disorder to qualify for the state’s medical cannabis program.

Opioid use disorder has been a major issue in New Jersey in recent years, and the policy change aims to help mitigate the issue.

Why it matters: Countless studies have found that increased access to medical cannabis is associated with a reduction in opioid use.

No patient should be forced to use opioids if they would rather make the safer choice. It’s fantastic to see New Jersey getting on the right side of this issue.

– This article was originally posted at Green Flower

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

Do you have a questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net

This article contains Third-Party Content submitted by third parties, including articles submitted through the HW Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of HW or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and HW does not endorse, guarantee or make representations concerning the accuracy and completeness of all third-party content. You acknowledge that by HW providing you with this internet portal that makes accessible to you the ability to view third-party content through the HW site, HW does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. HW expressly disclaims liability relating to such third-party content. HW and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, HW reserves the right to remove third-party content at any time in its sole discretion.

Archives

Select A Month

HempWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722